2024-09-21 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**Company Overview:** Johnson & Johnson is a multinational healthcare company specializing in pharmaceuticals, medical devices, and consumer healthcare products.

**Performance Summary:**

**1. Rate of Return vs. S&P 500:**
* JNJ has a cumulative return of 37.89%, compared to the S&P 500 (VOO) with a cumulative return of 133.16%.
* This results in a relative divergence of -95.27, placing it at the 8.74th percentile of historical performance relative to the S&P 500.

**2. Recent Price Movements:**
* Current Closing Price: $165.02
* 5-Day Moving Average: $166.09
* 20-Day Moving Average: $165.29
* 60-Day Moving Average: $158.33

**3. Technical Indicators:**
* RSI: 52.44 (Neutral)
* PPO: -0.21 (Slight Downward Pressure)
* Recent Relative Divergence (20-day): -0.86, indicating a short-term downward trend.
* Expected Return: 13.38%, representing the potential return on investment for the next 5-10 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | $22.45B |
| 2024-05-01 | 1.35 | $21.38B |
| 2024-02-16 | 1.68 | $21.39B |
| 2023-10-27 | 10.32 | $21.35B |
| 2024-02-16 | 10.32 | $21.35B |

The most recent earnings report for Q2 2024 showed EPS of $1.95, exceeding analysts' expectations by $0.15. Revenue also surpassed expectations, coming in at $22.45B. 

**Overall Analysis:**

Johnson & Johnson (JNJ) has lagged behind the S&P 500 in terms of cumulative returns. Despite recent strong earnings, the stock is currently experiencing a short-term downward trend, indicated by negative relative divergence and PPO index. However, the relatively neutral RSI suggests potential for a rebound.  The expected return of 13.38% for the next 5-10 years is an attractive prospect, especially considering the company's strong track record and diversified business model.  

Investors should consider the recent earnings performance and the company's long-term growth potential while evaluating the current market trends and technical indicators. 
